## RTX: RTX Corporation - XLI: Industrials

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 5.5% in lower entry zone (4.0-10.0%), top quartile (87th pct) cross-sectional ranking. Short-term MRS_5 (1.4%) confirms momentum alignment. Strong momentum (+1.6% 5-day acceleration). Outperforming sector by 4.3%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($178.21)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. RTX's Collins Aerospace demonstrates latest development in anti-jam technology**
- Source: Investing News Network | 20251222T141628 | Bullish | Relevance: 100%
- Collins Aerospace, an RTX business, unveiled its latest anti-jam Assured Positioning Navigation and Timing (APNT) technology at the U.S. Army's All-Domain Persistent Experiment. This "Small form factor Assured Precision Navigation and Timing solution" is the smallest APNT ground solution from Collins to date, designed to provide resilient navigation for ground vehicles, including robotic and autonomous platforms, even in denied and degraded GPS environments. The system successfully maintained assured navigation during the experiment despite significant jamming and spoofing.

**2. How Investors Are Reacting To RTX (RTX) Patriot And PhantomStrike Wins Amid Record U.S. Defense Budget**
- Source: Simply Wall Street | 20251221T000817 | Bullish | Relevance: 100%
- RTX (Raytheon) recently secured significant defense contracts for its Patriot missile system and PhantomStrike radar, amidst a record U.S. defense budget. These wins reinforce RTX's position as a key supplier in advanced defense systems, with the PhantomStrike potentially broadening its market to more compact radar solutions. While these contracts are promising, investors are also considering the broader earnings mix and potential shifts in defense spending priorities.

**3. RTX (RTX) Receives a Buy from J.P. Morgan**
- Source: The Globe and Mail | 20251220T100830 | Bullish | Relevance: 100%
- J.P. Morgan analyst Seth Seifman maintained a Buy rating on RTX (RTX) with a $200.00 price target. This follows a similar Buy rating from Citi's John Godyn, although DBS maintained a Hold rating. The company reported strong Q3 earnings with increased revenue and net profit, though corporate insider sentiment is negative due to recent share sales.

**4. RTX (RTX) Receives a Buy from J.P. Morgan**
- Source: The Globe and Mail | 20251220T100824 | Bullish | Relevance: 100%
- J.P. Morgan analyst Seth Seifman maintained a Buy rating on RTX (RTX) with a price target of $200.00. This follows another Buy rating from Citi, despite a Hold rating from DBS. The company reported strong quarterly revenues of $22.48 billion and a net profit of $1.92 billion for the quarter ending September 30, though corporate insider sentiment is negative due to increased selling activity.

**5. Romania orders more Patriot missile defenses in a $168M deal**
- Source: Stock Titan | 20251220T070915 | Bullish | Relevance: 100%
- RTX's Raytheon business has secured a $168 million foreign military sales contract to provide Romania with Patriot air and missile defense system equipment, marking Romania's second such order within a year. The contract includes radar, a command-and-control system, launchers, and support equipment, reinforcing Patriot's role as a combat-proven air defense solution across 19 countries. This deal contributes to RTX's recent defense wins, following other Patriot orders in 2025 from Germany, the Netherlands, and Spain.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | JP Morgan | $200 | $195 | +3% |
| 2025-12-12 | Citigroup | $211 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | JP Morgan | main | Overweight |
| 2025-12-12 | Citigroup | init | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.00M) |
| Sells | 4 ($2.14M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 47.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 9.2% (+0.6%)
- Blackrock Inc.: 7.5% (+2.8%)
- State Street Corpora: 6.8% (-19.0%)
- Capital Research Glo: 5.7% (+1.1%)
- JPMORGAN CHASE & CO: 4.5% (+101.3%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Momentum building: MRS_20 improving +1.6% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.55 elevated, pricing in significant growth expectations. Forward P/E 27.4x stretched relative to 9% growth. Balance sheet: $4.0B free cash flow. Insider selling cluster ($2.1M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $249.0B |
| Beta | 0.43 |
| 52W Range | $112.27 - $185.87 |
| Short Interest | 0.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.55 |
| Forward P/E | 27.4 |
| Current P/E | 29.9 |
| YoY Growth | 9.2% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 3.9% to 5.5% (+1.6% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 87th percentile. MRS_5 at 1.4% confirms short-term momentum alignment. AM_20 at 6.1% shows strong absolute momentum above own 20MA. Outperforming sector by 4.3pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.06), confirming momentum. OFD pattern: +MLL (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.46% (CS: 87) | Strong |
| RSI_14 | 67.7 | Neutral |
| MACD Histogram | 1.06 | Bullish |
| vs SMA20 | 1.061x | Above |
| vs SMA50 | 1.069x | Above |
| vs SMA200 | 1.225x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $185.69
- **Stop Loss:** $178.21 (4.0% risk)
- **Target:** $196.91 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 120
- **Position Value:** $22,282.80
- **Portfolio %:** 22.28%
- **Risk Dollars:** $900.00
- **Risk Per Trade:** 0.90%
- **Modifiers:** L1 120% | L2 75% | Combined 0.90x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | WEAKENING (Zone B) | 0.75x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-01-27 (Est: $1.47)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.41 | $1.70 | +20.6% |
| 2025Q2 | $1.43 | $1.56 | +9.5% |
| 2025Q1 | $1.37 | $1.47 | +7.5% |
| 2024Q4 | $1.38 | $1.54 | +11.8% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_20*